← Human Trials & Peer-Reviewed Studies

Effects of acute and chronic exercise on disulfide-linked growth hormone variants.

Plain-language guide to PMID 19204593 (2009): randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Key Facts

PMID
19204593
Journal
Medicine and science in sports and exercise
Year
2009
Study type
Randomized Controlled Trial
Authors
Pierce JR et al. (7 authors)
DOI
10.1249/MSS.0b013e31818c6d93

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.

To test the hypothesis that the appearance of disulfide-linked growth hormone (GH) aggregates during and after an acute resistance exercise test (ARET) in men could be influenced by chronic physical training.

Who Took Part

By PubMed's age tags, the people studied were adults, men only.

Before and after chronic training, subjects performed an ARET (six sets of 10 repetition-maximum squat) and had venous blood drawn pre-, mid-, and post-ARET (0, 15, and 30 min postexercise).

How the Study Was Run

In design terms this was a randomized study.

Random assignment meant chance, not the researchers, decided who got Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and who got the comparison, which limits bias.

Data were analyzed using repeated-measures ANOVA.

What Was Measured

Topics PubMed links to this paper include Body Fat Distribution, Body Mass Index, Disulfides, Glutathione, Human Growth Hormone, Immunoassay and Military Personnel.

What This Means in Plain Language

The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2009 (Medicine and science in sports and exercise), a journal based in United States.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.

Our Notes on the Compound

Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.